Offres d'emploi
Trouvez des postes près de chez vous, sur site, hybrides ou à distance.- Emplois similaires à : Scientist - Infectious Diseases - Oxford
Scientist - Infectious Diseases - Oxford
ImmunocoreBotley
Scientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreChiltonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreCharltonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreBroadwellScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreFordScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreBradwellScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreUptonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreMiltonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreSouth HinkseyScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreCowleyScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreBartonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreWortonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreSwinfordScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreKidlingtonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreStanton HarcourtScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreBladonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreSutton CourtenayScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreLong WittenhamScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreNewingtonScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreDorchesterScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreLongworthScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreNorth LeighScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreChalgroveScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreEast HanneyScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreWilcoteScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio